Mission Statement
To address the major unmet clinical and patient needs in endocrinology by creating products for the lifelong treatment of chronic conditions.
Overview
Diurnal is committed to transparency in its interactions. Diurnal commits to following the Association of British Pharmaceutical Industry (ABPI) Code of Practice which has clear requirements for transparency. Diurnal has published details of its transfers of value required under the ABPI Code on the ABPI website and on this website.
Clinical Trial Data Access Request
Diurnal is committed to public disclosure and transparency of our clinical study data. Diurnal is committed to transparency in clinical trials and publishes the protocols and results of its clinical trials on the website www.clinicaltrials.gov. Qualified scientific and medical researchers may request clinical trial data. Diurnal agrees to share patient- and study-level data and protocols from clinical trials in patients, for medicines and indications approved by national regulatory authorities.